OPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITY
From MaRDI portal
(Redirected from Publication:6173429)
Recommendations
- MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS
- Numerical solution of an optimal control model of dendritic cell treatment of a growing tumour
- Tumor control, elimination, and escape through a compartmental model of dendritic cell therapy for melanoma
- A tumor-immune model with mixed immunotherapy and chemotherapy: qualitative analysis and optimal control
- Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study
Cites work
- A strategy of optimal efficacy of T11 target structure in the treatment of brain tumor
- Bifurcation analysis of a delayed mathematical model for tumor growth
- Cancer immunotherapy, mathematical modeling and optimal control
- Cancer Modelling and Simulation
- Chaotic dynamics of a delayed tumor-immune interaction model
- scientific article; zbMATH DE number 3167340 (Why is no real title available?)
- scientific article; zbMATH DE number 3505708 (Why is no real title available?)
- scientific article; zbMATH DE number 1915402 (Why is no real title available?)
- Immunodominance analysis through interactions of CD8^+ T cells and DCs in lymph nodes
- Influence of multiple delays in brain tumor and immune system interaction with T11 target structure as a potent stimulator
- Is the Allee effect relevant to stochastic cancer model?
- Modeling immunotherapy of the tumor -- immune interaction
- Modeling the dynamics of glioma-immune surveillance
- Numerical solution of an optimal control model of dendritic cell treatment of a growing tumour
- Optimal control applied to biological models.
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS
- Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective
- Role of optimal control theory in cancer chemotherapy
- Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
- The combined effects of optimal control in cancer remission
- The impact of distributed time delay in a tumor-immune interaction system
- The impact of immunotherapy on a glioma immune interaction model
- Theory of functional differential equations. 2nd ed
Cited in
(13)- Dendritic immunotherapy improvement for an optimal control murine model
- An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol
- Parameter estimation and treatment optimization in a stochastic model for immunotherapy of cancer
- Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells
- Numerical solution of an optimal control model of dendritic cell treatment of a growing tumour
- Tumor control, elimination, and escape through a compartmental model of dendritic cell therapy for melanoma
- A tumor-Immune interaction model with the effect of impulse therapy
- Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study
- Dynamic behaviors of a cholera model with nonlinear incidences, multiple transmission pathways, and imperfect vaccine
- Modelling and analysis of a fractional-order epidemic model incorporating genetic algorithm-based optimization
- System variable reduction and global sensitivity analysis for a complex model of cancer cell differentiation
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
- Dynamical behavior of combinational immune boost against tumor
This page was built for publication: OPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITY
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6173429)
